Showing results (271-280 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|January 19, 2021
Cost-effectiveness of CYP2C19-guided antiplatelet therapy for acute coronary syndromes in SingaporeJi Heon Kim, Doreen Su-Yin Tan, Mark Yan Yee Chan
The Pharmacogenomics Journal|November 26, 2021
Pharmacogenomic analysis of a genetically distinct Indigenous populationArvind Jaya Shankar, Sudhir Jadhao, Wendy Hoy, et al.
The Pharmacogenomics Journal|October 21, 2021
Nine-gene pharmacogenomics profile service: The Mayo Clinic experienceEric T Matey, Ashley Kate Ragan, Lance J Oyen, et al.
The Pharmacogenomics Journal|February 12, 2022
UGT1A1 genetic variants are associated with increases in bilirubin levels in rheumatoid arthritis patients treated with sarilumabNan Lin, Amy Damask, Anita Boyapati, et al.
The Pharmacogenomics Journal|January 30, 2022
Impact of CYP2C19 metaboliser status on SSRI response: a retrospective study of 9500 participants of the Australian Genetics of Depression StudyAdrian I Campos, Enda M Byrne, Brittany L Mitchell, et al.
The Pharmacogenomics Journal|February 1, 2022
Identification of sex-specific genetic associations in response to opioid analgesics in a White, non-Hispanic cohort from Southeast MinnesotaGuilherme S Lopes, Jaime L Lopes, Suzette J Bielinski, et al.
The Pharmacogenomics Journal|September 13, 2018
Concordance between glucose-6-phosphate dehydrogenase (G6PD) genotype and phenotype and rasburicase use in patients with hematologic malignanciesKatherine M Robinson, Wenjian Yang, Cyrine E Haidar, et al.
The Pharmacogenomics Journal|October 17, 2019
Genetic and epigenetic polymorphisms of eNOS and CYP2D6 in mainland Chinese Tibetan, Mongolian, Uygur, and Han populationsGuangzhao Qi, Shengju Yin, Guoliang Zhang, et al.
Pageof 135